A federal judge in Texas this week ruled that emails exchanged between Medtronic (NYSE:MDT) and Neurovision hashing out a settlement in their patent infringement dispute constitute a valid agreement, setting the stage for a hearing on whether the subsequent, unsigned contract is binding. Neurovision sued Medtronic in the the U.S. District Court for Eastern Texas in February 2016, […]
September 24, 2014 by Brad Perriello
Los Angeles, September 5, 2014 – A Los Angeles federal judge issued a permanent injunction earlier this week against NuVasive, Inc. (NUVA), forever barring the medical device manufacturer from using the trademark NEUROVISION to promote or sell medical devices in the United States.
Los Angeles, April 3, 2014 – A federal jury awarded $30 million yesterday in a trademark infringement case brought by Neurovision Medical Products against NuVasive.
UPDATED April 7, 2014, with comment from NeuroVision
The Limerick, Pa.-based medical device company said its "preliminary financial goals" for 2013 are for sales growth of 11%-13% and adjusted EPS of $4.70-$4.90.
NuVasive Inc. (NSDQ:NUVA) won a big legal victory yesterday when a federal appeals court reversed a lower court’s $60 million decision in favor of NeuroVision Medical Products, rebuking the lower court judge in the process.
The decision means the case pitting the medical device companies against each other will be re-tried under a different district court judge.
NuVasive appealed the decision, arguing in March that the judge who handled the case "fundamentally misunderstood trademark law" and "exhibited hostility toward NuVasive’s counsel in front of the jury."